Uniway Pharmaceuticals Private Limited

Uniway Pharmaceuticals Private Limited - chemicals in Patna, Bihar, India. Directors, charges & compliance details.
CIN U51909BR2015PTC024430 Incorporated 17 June 2015 ROC Patna HQ Patna, Bihar, India
Struck Off Private Limited Company chemicals
Data last updated
Revenue · FY 2018
₹13.91 Lakh
▼ 55% YoY
Net loss · FY 2018
₹27,852
Net margin -2%
EBITDA · FY 2018
₹30,547
EBITDA margin 2.2%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Uniway Pharmaceuticals Private Limited

Data last updated:

Uniway Pharmaceuticals Private Limited was a private limited company based in Patna, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 17 June 2015.

The company was registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2015PTC024430. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It was led by directors Ashfaque Ahmad Momin (Managing Director) and Jawaid Iqbal Wajidi.

Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Flat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006.

As per the financials filed for FY 2018, the company reported a revenue of ₹13.91 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹27,852 (net margin -2%) and EBITDA of ₹30,547 (EBITDA margin 2.2%).

Company details

CIN U51909BR2015PTC024430
Registration Number 024430
Incorporation Date 17 June 2015
ROC Patna
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2018
Date of Balance Sheet 31 March 2018
Compliance Status Active Non-Compliant

Contact details

Uniway Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals

To see the full contact details of Uniway Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Uniway Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Uniway Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Uniway Pharmaceuticals Private Limited, buy the company report.

Financials of Uniway Pharmaceuticals Private Limited

FY 2018 filings available

Uniway Pharmaceuticals Private Limited reported revenue of ₹13.91 Lakh (down 55% YoY) for FY 2018.

Revenue · FY 2018
₹13.91 Lakh ▼ 55%
Net loss · FY 2018
₹27,852 margin -2%
EBITDA · FY 2018
₹30,547 margin 2.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 55%
EBITDA CAGR growth
1 year
▼ 70%

Revenue fell 55% in the latest year. EBITDA fell 70% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹30,547
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹27,852
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin2.2%
Net Profit Margin-2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uniway Pharmaceuticals Private Limited, buy the company report.

Board of directors of Uniway Pharmaceuticals Private Limited

Uniway Pharmaceuticals has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Jawaid Iqbal WajidiDirector17 Jun 201511 Years 4 MonthsAs last reported
Ashfaque Ahmad MominManaging Director17 Jun 201511 Years 4 MonthsAs last reported

Peer comparison

Uniway Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dbrmd Pharmaceuticals Private Limited₹13.95 Lakh (FY 2018)Kolkata, West Bengal, India
Qrent Pharmaceuticals Private Limited₹13.93 Lakh (FY 2024)66.0%Gurugram, Haryana, India
Uniway Pharmaceuticals Private Limitedthis company₹13.91 Lakh (FY 2018)-₹27,852-2%-55.0%Patna, Bihar, India
Biovams Pharmaceuticals Private Limited₹13.9 Lakh (FY 2025)-87.0%Ahmedabad, Gujarat, India
Crinat Pharmaceuticals Private Limited₹13.89 Lakh (FY 2025)-3.0%Namakkal, Tamil Nadu, India
Decorum Pharmaceuticals Private Limited₹13.87 Lakh (FY 2024)-5.0%Patna, Bihar, India

To see the full peer comparison of Uniway Pharmaceuticals Private Limited, buy the company report.

Auditor

Uniway Pharmaceuticals Private Limited is audited by GUPTA SACHDEVA & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
GUPTA SACHDEVA & COFY 2017006706N

Shareholding

The shareholding of Uniway Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Uniway Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uniway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Uniway Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Uniway Pharmaceuticals Private Limited, buy the company report.

Recent activity

Uniway Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Ashfaque Ahmad Momin was appointed as Managing Director on 17 Jun 2015.

AGM
Uniway Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records.
Filing
Uniway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Patna.
Appointed
Ashfaque Ahmad Momin was appointed as Managing Director.
Appointed
Jawaid Iqbal Wajidi was appointed as Director.
Incorporation
17 Jun 2015
Uniway Pharmaceuticals Private Limited was registered on 17 Jun 2015 with Roc Patna & aged 11 years 4 months as per MCA records.

Frequently asked questions

Uniway Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Uniway Pharmaceuticals was a private limited company based in Patna, Bihar, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 17 June 2015 and is registered under CIN U51909BR2015PTC024430. The company has been struck off by the Registrar of Companies and is no longer operational.

Uniway Pharmaceuticals had 2 directors:

The CIN (Corporate Identification Number) of Uniway Pharmaceuticals is U51909BR2015PTC024430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Uniway Pharmaceuticals is at Flat No. 102 1st Floor Zenith Appartment Sultanganj Mahendru, Patna, Bihar, India – 800006.

Uniway Pharmaceuticals was incorporated on 17 June 2015. It is registered with the Registrar of Companies, Patna.

The latest financial statements of Uniway Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from FY 2016 are in the company report.

No. Uniway Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.

Uniway Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.

The peers of Uniway Pharmaceuticals by revenue are Dbrmd Pharmaceuticals Private Limited, Qrent Pharmaceuticals Private Limited, Biovams Pharmaceuticals Private Limited, Crinat Pharmaceuticals Private Limited, Decorum Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Ashfaque Ahmad Momin was appointed as Managing Director on 17 Jun 2015. Jawaid Iqbal Wajidi was appointed as Director on 17 Jun 2015.